カテゴリー： QYResearch, 世界

世界の緑膿菌肺炎治療薬市場 2019年

【英語タイトル】Global Pseudomonas Aeruginosa Pneumonia Drug Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X13859）・商品コード：DATA909X13859
・発行会社（調査会社）：QYResearch
・発行日：2019年11月20日（※2024年版があります。お問い合わせください）
・ページ数：107
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、緑膿菌肺炎治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、アエルシン、EV-035、MEDI-3902、パノバクマブ、その他に、用途別には、病院、クリニック、その他にセグメント区分し、緑膿菌肺炎治療薬の世界市場を分析しました。


・エグゼクティブ・サマリー
・緑膿菌肺炎治療薬の世界市場概要
・緑膿菌肺炎治療薬の製造コスト構成分析
・緑膿菌肺炎治療薬の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・緑膿菌肺炎治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・緑膿菌肺炎治療薬のセグメント分析（種類別）
（アエルシン、EV-035、MEDI-3902、パノバクマブ、その他）
・緑膿菌肺炎治療薬のセグメント分析（用途別）
（病院、クリニック、その他）
・緑膿菌肺炎治療薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Aridis Pharmaceuticals LLC、Emergent BioSolutions Inc、MedImmune LLC、Polyphor Ltd、）
・緑膿菌肺炎治療薬の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Pseudomonas Aeruginosa Pneumonia Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Pseudomonas Aeruginosa Pneumonia Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Pseudomonas Aeruginosa Pneumonia Drug market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Pseudomonas Aeruginosa Pneumonia Drug in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Pseudomonas Aeruginosa Pneumonia Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Aridis Pharmaceuticals LLC
Emergent BioSolutions Inc
MedImmune LLC
Polyphor Ltd
…

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Aerucin
EV-035
MEDI-3902
Panobacumab
Others

Segment by Application
Hospital
Clinic
Others

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Pseudomonas Aeruginosa Pneumonia Drug
1.1 Definition of Pseudomonas Aeruginosa Pneumonia Drug
1.2 Pseudomonas Aeruginosa Pneumonia Drug Segment by Type
1.2.1 Global Pseudomonas Aeruginosa Pneumonia Drug Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Aerucin
1.2.3 EV-035
1.2.4 MEDI-3902
1.2.5 Panobacumab
1.2.6 Others
1.3 Pseudomonas Aeruginosa Pneumonia Drug Segment by Applications
1.3.1 Global Pseudomonas Aeruginosa Pneumonia Drug Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Pseudomonas Aeruginosa Pneumonia Drug Overall Market
1.4.1 Global Pseudomonas Aeruginosa Pneumonia Drug Revenue (2014-2025)
1.4.2 Global Pseudomonas Aeruginosa Pneumonia Drug Production (2014-2025)
1.4.3 North America Pseudomonas Aeruginosa Pneumonia Drug Status and Prospect (2014-2025)
1.4.4 Europe Pseudomonas Aeruginosa Pneumonia Drug Status and Prospect (2014-2025)
1.4.5 China Pseudomonas Aeruginosa Pneumonia Drug Status and Prospect (2014-2025)
1.4.6 Japan Pseudomonas Aeruginosa Pneumonia Drug Status and Prospect (2014-2025)
1.4.7 Southeast Asia Pseudomonas Aeruginosa Pneumonia Drug Status and Prospect (2014-2025)
1.4.8 India Pseudomonas Aeruginosa Pneumonia Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Pseudomonas Aeruginosa Pneumonia Drug
2.3 Manufacturing Process Analysis of Pseudomonas Aeruginosa Pneumonia Drug
2.4 Industry Chain Structure of Pseudomonas Aeruginosa Pneumonia Drug

3 Development and Manufacturing Plants Analysis of Pseudomonas Aeruginosa Pneumonia Drug
3.1 Capacity and Commercial Production Date
3.2 Global Pseudomonas Aeruginosa Pneumonia Drug Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Pseudomonas Aeruginosa Pneumonia Drug
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Pseudomonas Aeruginosa Pneumonia Drug Production and Capacity Analysis
4.2 Pseudomonas Aeruginosa Pneumonia Drug Revenue Analysis
4.3 Pseudomonas Aeruginosa Pneumonia Drug Price Analysis
4.4 Market Concentration Degree

5 Pseudomonas Aeruginosa Pneumonia Drug Regional Market Analysis
5.1 Pseudomonas Aeruginosa Pneumonia Drug Production by Regions
5.1.1 Global Pseudomonas Aeruginosa Pneumonia Drug Production by Regions
5.1.2 Global Pseudomonas Aeruginosa Pneumonia Drug Revenue by Regions
5.2 Pseudomonas Aeruginosa Pneumonia Drug Consumption by Regions
5.3 North America Pseudomonas Aeruginosa Pneumonia Drug Market Analysis
5.3.1 North America Pseudomonas Aeruginosa Pneumonia Drug Production
5.3.2 North America Pseudomonas Aeruginosa Pneumonia Drug Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Pseudomonas Aeruginosa Pneumonia Drug Import and Export
5.4 Europe Pseudomonas Aeruginosa Pneumonia Drug Market Analysis
5.4.1 Europe Pseudomonas Aeruginosa Pneumonia Drug Production
5.4.2 Europe Pseudomonas Aeruginosa Pneumonia Drug Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Pseudomonas Aeruginosa Pneumonia Drug Import and Export
5.5 China Pseudomonas Aeruginosa Pneumonia Drug Market Analysis
5.5.1 China Pseudomonas Aeruginosa Pneumonia Drug Production
5.5.2 China Pseudomonas Aeruginosa Pneumonia Drug Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Pseudomonas Aeruginosa Pneumonia Drug Import and Export
5.6 Japan Pseudomonas Aeruginosa Pneumonia Drug Market Analysis
5.6.1 Japan Pseudomonas Aeruginosa Pneumonia Drug Production
5.6.2 Japan Pseudomonas Aeruginosa Pneumonia Drug Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Pseudomonas Aeruginosa Pneumonia Drug Import and Export
5.7 Southeast Asia Pseudomonas Aeruginosa Pneumonia Drug Market Analysis
5.7.1 Southeast Asia Pseudomonas Aeruginosa Pneumonia Drug Production
5.7.2 Southeast Asia Pseudomonas Aeruginosa Pneumonia Drug Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Pseudomonas Aeruginosa Pneumonia Drug Import and Export
5.8 India Pseudomonas Aeruginosa Pneumonia Drug Market Analysis
5.8.1 India Pseudomonas Aeruginosa Pneumonia Drug Production
5.8.2 India Pseudomonas Aeruginosa Pneumonia Drug Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Pseudomonas Aeruginosa Pneumonia Drug Import and Export

6 Pseudomonas Aeruginosa Pneumonia Drug Segment Market Analysis (by Type)
6.1 Global Pseudomonas Aeruginosa Pneumonia Drug Production by Type
6.2 Global Pseudomonas Aeruginosa Pneumonia Drug Revenue by Type
6.3 Pseudomonas Aeruginosa Pneumonia Drug Price by Type

7 Pseudomonas Aeruginosa Pneumonia Drug Segment Market Analysis (by Application)
7.1 Global Pseudomonas Aeruginosa Pneumonia Drug Consumption by Application
7.2 Global Pseudomonas Aeruginosa Pneumonia Drug Consumption Market Share by Application (2014-2019)

8 Pseudomonas Aeruginosa Pneumonia Drug Major Manufacturers Analysis
8.1 Aridis Pharmaceuticals LLC
8.1.1 Aridis Pharmaceuticals LLC Pseudomonas Aeruginosa Pneumonia Drug Production Sites and Area Served
8.1.2 Aridis Pharmaceuticals LLC Product Introduction, Application and Specification
8.1.3 Aridis Pharmaceuticals LLC Pseudomonas Aeruginosa Pneumonia Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Emergent BioSolutions Inc
8.2.1 Emergent BioSolutions Inc Pseudomonas Aeruginosa Pneumonia Drug Production Sites and Area Served
8.2.2 Emergent BioSolutions Inc Product Introduction, Application and Specification
8.2.3 Emergent BioSolutions Inc Pseudomonas Aeruginosa Pneumonia Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 MedImmune LLC
8.3.1 MedImmune LLC Pseudomonas Aeruginosa Pneumonia Drug Production Sites and Area Served
8.3.2 MedImmune LLC Product Introduction, Application and Specification
8.3.3 MedImmune LLC Pseudomonas Aeruginosa Pneumonia Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Polyphor Ltd
8.4.1 Polyphor Ltd Pseudomonas Aeruginosa Pneumonia Drug Production Sites and Area Served
8.4.2 Polyphor Ltd Product Introduction, Application and Specification
8.4.3 Polyphor Ltd Pseudomonas Aeruginosa Pneumonia Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served

9 Development Trend of Analysis of Pseudomonas Aeruginosa Pneumonia Drug Market
9.1 Global Pseudomonas Aeruginosa Pneumonia Drug Market Trend Analysis
9.1.1 Global Pseudomonas Aeruginosa Pneumonia Drug Market Size (Volume and Value) Forecast 2019-2025
9.2 Pseudomonas Aeruginosa Pneumonia Drug Regional Market Trend
9.2.1 North America Pseudomonas Aeruginosa Pneumonia Drug Forecast 2019-2025
9.2.2 Europe Pseudomonas Aeruginosa Pneumonia Drug Forecast 2019-2025
9.2.3 China Pseudomonas Aeruginosa Pneumonia Drug Forecast 2019-2025
9.2.4 Japan Pseudomonas Aeruginosa Pneumonia Drug Forecast 2019-2025
9.2.5 Southeast Asia Pseudomonas Aeruginosa Pneumonia Drug Forecast 2019-2025
9.2.6 India Pseudomonas Aeruginosa Pneumonia Drug Forecast 2019-2025
9.3 Pseudomonas Aeruginosa Pneumonia Drug Market Trend (Product Type)
9.4 Pseudomonas Aeruginosa Pneumonia Drug Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Pseudomonas Aeruginosa Pneumonia Drug Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Pseudomonas Aeruginosa Pneumonia Drug
Table Global Pseudomonas Aeruginosa Pneumonia Drug Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Pseudomonas Aeruginosa Pneumonia Drug Production Market Share by Types in 2018
Figure Aerucin Product Picture
Figure EV-035 Product Picture
Figure MEDI-3902 Product Picture
Figure Panobacumab Product Picture
Figure Others Product Picture
Table Global Pseudomonas Aeruginosa Pneumonia Drug Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Pseudomonas Aeruginosa Pneumonia Drug Consumption Market Share by Applications in 2018
Figure Hospital
Figure Clinic
Figure Others
Figure Global Pseudomonas Aeruginosa Pneumonia Drug Revenue (Million USD) (2014-2025)
Figure Global Pseudomonas Aeruginosa Pneumonia Drug Production (K Pcs) (2014-2025)
Figure North America Pseudomonas Aeruginosa Pneumonia Drug Market Size (Million USD) (2014-2025)
Figure Europe Pseudomonas Aeruginosa Pneumonia Drug Market Size (Million USD) (2014-2025)
Figure China Pseudomonas Aeruginosa Pneumonia Drug Market Size (Million USD) (2014-2025)
Figure Japan Pseudomonas Aeruginosa Pneumonia Drug Market Size (Million USD) (2014-2025)
Figure Southeast Asia Pseudomonas Aeruginosa Pneumonia Drug Market Size (Million USD) (2014-2025)
Figure India Pseudomonas Aeruginosa Pneumonia Drug Market Size (Million USD) (2014-2025)
Table Pseudomonas Aeruginosa Pneumonia Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Pseudomonas Aeruginosa Pneumonia Drug in 2018
Figure Manufacturing Process Analysis of Pseudomonas Aeruginosa Pneumonia Drug
Figure Industry Chain Structure of Pseudomonas Aeruginosa Pneumonia Drug
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Pseudomonas Aeruginosa Pneumonia Drug Manufacturing Plants Distribution
Table Pseudomonas Aeruginosa Pneumonia Drug Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Pseudomonas Aeruginosa Pneumonia Drug Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Pseudomonas Aeruginosa Pneumonia Drug Production (K Pcs) of Major Manufacturers (2014-2019)
Table Pseudomonas Aeruginosa Pneumonia Drug Production Market Share of Major Manufacturers (2014-2019)
Figure Pseudomonas Aeruginosa Pneumonia Drug Production Share by Manufacturers in 2018
Table Pseudomonas Aeruginosa Pneumonia Drug Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Pseudomonas Aeruginosa Pneumonia Drug Revenue Market Share of Major Manufacturers (2014-2019)
Figure Pseudomonas Aeruginosa Pneumonia Drug Revenue Share by Manufacturers in 2018
Table Pseudomonas Aeruginosa Pneumonia Drug Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Pseudomonas Aeruginosa Pneumonia Drug Production by Regions 2014-2019 (K Pcs)
Table Global Pseudomonas Aeruginosa Pneumonia Drug Production Market Share by Regions 2014-2019
Figure Global Pseudomonas Aeruginosa Pneumonia Drug Production Market Share by Regions in 2018
Table Global Pseudomonas Aeruginosa Pneumonia Drug Revenue by Regions 2014-2019 (Million USD)
Table Global Pseudomonas Aeruginosa Pneumonia Drug Revenue Market Share by Regions 2014-2019
Figure Global Pseudomonas Aeruginosa Pneumonia Drug Revenue Market Share by Regions in 2018
Table Global Pseudomonas Aeruginosa Pneumonia Drug Consumption by Regions 2014-2019 (K Pcs)
Table Global Pseudomonas Aeruginosa Pneumonia Drug Consumption Market Share by Regions 2014-2019
Figure North America Pseudomonas Aeruginosa Pneumonia Drug Production Growth Rate 2014-2019 (K Pcs)
Figure North America Pseudomonas Aeruginosa Pneumonia Drug Revenue Growth Rate 2014-2019 (Million USD)
Table North America Pseudomonas Aeruginosa Pneumonia Drug Production, Consumption Import and Export (K Pcs)
Figure Europe Pseudomonas Aeruginosa Pneumonia Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Pseudomonas Aeruginosa Pneumonia Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Pseudomonas Aeruginosa Pneumonia Drug Production, Consumption Import and Export (K Pcs)
Figure China Pseudomonas Aeruginosa Pneumonia Drug Production Growth Rate 2014-2019 (K Pcs)
Figure China Pseudomonas Aeruginosa Pneumonia Drug Revenue Growth Rate 2014-2019 (Million USD)
Table China Pseudomonas Aeruginosa Pneumonia Drug Production, Consumption Import and Export (K Pcs)
Figure Japan Pseudomonas Aeruginosa Pneumonia Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Pseudomonas Aeruginosa Pneumonia Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Pseudomonas Aeruginosa Pneumonia Drug Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Pseudomonas Aeruginosa Pneumonia Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Pseudomonas Aeruginosa Pneumonia Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Pseudomonas Aeruginosa Pneumonia Drug Production, Consumption Import and Export (K Pcs)
Figure India Pseudomonas Aeruginosa Pneumonia Drug Production Growth Rate 2014-2019 (K Pcs)
Figure India Pseudomonas Aeruginosa Pneumonia Drug Revenue Growth Rate 2014-2019 (Million USD)
Table India Pseudomonas Aeruginosa Pneumonia Drug Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Pseudomonas Aeruginosa Pneumonia Drug Market Share by Application (2014-2019)
Figure Global Value (Consumption) Pseudomonas Aeruginosa Pneumonia Drug Market Share by Application (2014-2019)
Table Aridis Pharmaceuticals LLC Pseudomonas Aeruginosa Pneumonia Drug Production Sites and Area Served
Table Aridis Pharmaceuticals LLC Pseudomonas Aeruginosa Pneumonia Drug Product Introduction, Application and Specification
Table Aridis Pharmaceuticals LLC Pseudomonas Aeruginosa Pneumonia Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Aridis Pharmaceuticals LLC Pseudomonas Aeruginosa Pneumonia Drug Production Growth Rate (2014-2019)
Table Aridis Pharmaceuticals LLC Pseudomonas Aeruginosa Pneumonia Drug Production Market Share (2014-2019)
Figure Aridis Pharmaceuticals LLC Pseudomonas Aeruginosa Pneumonia Drug Revenue Market Share (2014-2019)
Table Aridis Pharmaceuticals LLC Pseudomonas Aeruginosa Pneumonia Drug Main Business and Markets Served
Table Emergent BioSolutions Inc Pseudomonas Aeruginosa Pneumonia Drug Production Sites and Area Served
Table Emergent BioSolutions Inc Pseudomonas Aeruginosa Pneumonia Drug Product Introduction, Application and Specification
Table Emergent BioSolutions Inc Pseudomonas Aeruginosa Pneumonia Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Emergent BioSolutions Inc Pseudomonas Aeruginosa Pneumonia Drug Production Growth Rate (2014-2019)
Table Emergent BioSolutions Inc Pseudomonas Aeruginosa Pneumonia Drug Production Market Share (2014-2019)
Figure Emergent BioSolutions Inc Pseudomonas Aeruginosa Pneumonia Drug Revenue Market Share (2014-2019)
Table Emergent BioSolutions Inc Pseudomonas Aeruginosa Pneumonia Drug Main Business and Markets Served
Table MedImmune LLC Pseudomonas Aeruginosa Pneumonia Drug Production Sites and Area Served
Table MedImmune LLC Pseudomonas Aeruginosa Pneumonia Drug Product Introduction, Application and Specification
Table MedImmune LLC Pseudomonas Aeruginosa Pneumonia Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table MedImmune LLC Pseudomonas Aeruginosa Pneumonia Drug Production Growth Rate (2014-2019)
Table MedImmune LLC Pseudomonas Aeruginosa Pneumonia Drug Production Market Share (2014-2019)
Figure MedImmune LLC Pseudomonas Aeruginosa Pneumonia Drug Revenue Market Share (2014-2019)
Table MedImmune LLC Pseudomonas Aeruginosa Pneumonia Drug Main Business and Markets Served
Table Polyphor Ltd Pseudomonas Aeruginosa Pneumonia Drug Production Sites and Area Served
Table Polyphor Ltd Pseudomonas Aeruginosa Pneumonia Drug Product Introduction, Application and Specification
Table Polyphor Ltd Pseudomonas Aeruginosa Pneumonia Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Polyphor Ltd Pseudomonas Aeruginosa Pneumonia Drug Production Growth Rate (2014-2019)
Table Polyphor Ltd Pseudomonas Aeruginosa Pneumonia Drug Production Market Share (2014-2019)
Figure Polyphor Ltd Pseudomonas Aeruginosa Pneumonia Drug Revenue Market Share (2014-2019)
Table Polyphor Ltd Pseudomonas Aeruginosa Pneumonia Drug Main Business and Markets Served
Figure Global Pseudomonas Aeruginosa Pneumonia Drug Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Pseudomonas Aeruginosa Pneumonia Drug Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Pseudomonas Aeruginosa Pneumonia Drug Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Pseudomonas Aeruginosa Pneumonia Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Pseudomonas Aeruginosa Pneumonia Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Pseudomonas Aeruginosa Pneumonia Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Pseudomonas Aeruginosa Pneumonia Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Pseudomonas Aeruginosa Pneumonia Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Pseudomonas Aeruginosa Pneumonia Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Pseudomonas Aeruginosa Pneumonia Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Pseudomonas Aeruginosa Pneumonia Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Pseudomonas Aeruginosa Pneumonia Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Pseudomonas Aeruginosa Pneumonia Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Pseudomonas Aeruginosa Pneumonia Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Pseudomonas Aeruginosa Pneumonia Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Pseudomonas Aeruginosa Pneumonia Drug by Type (2019-2025)
Table Global Consumption (K Pcs) of Pseudomonas Aeruginosa Pneumonia Drug by Application (2019-2025)
Table Pseudomonas Aeruginosa Pneumonia Drug Distributors List
Table Pseudomonas Aeruginosa Pneumonia Drug Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Aridis Pharmaceuticals LLC、Emergent BioSolutions Inc、MedImmune LLC、Polyphor Ltd、

★調査レポート[世界の緑膿菌肺炎治療薬市場 2019年] (コード：DATA909X13859)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の緑膿菌肺炎治療薬市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 緑膿菌感染症治療の世界市場：規模・現状・予測2019-2025
    DATA909X18876 / QYResearch / 2019年11月25日 / ※当調査レポートでは、緑膿菌感染症治療の世界市場について調査・分析し、緑膿菌感染症治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（鼻、経口、静脈内）、用途別（病院薬局、小売薬局、オンライン薬局）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の緑膿菌感染症治療市場動向 ・主要企業別マーケットシェア ・緑膿菌感染症治療の種類別市場規模2014-2019 （鼻、経口、静脈内） ・緑膿菌感染症治療の用途別市場規模2014-2019 （病院薬局、小売薬局、オンライン薬局） ・緑膿菌感染症治療の北米市場：主要企業・種類別/用途別市場規模 ・緑膿菌感染症治療のヨーロッパ市場：主要企業・種類別/用途別市場規模...In 2018, the global Pseudomonas Aeruginosa Infection Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Pseudomonas Aeruginosa Infection Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Pseudomonas Aeruginosa Infection Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America. The key players covered in this study Allergan Teva Pharmaceutical Industries Pfizer Lupin Pharmaceuticals AstraZeneca Merck Bristol-Myers Squibb Janssen...
  • 世界の耐性緑膿菌感染症薬市場 2019年
    DATA909X14315 / QYResearch / 2019年11月20日 / ※本調査レポートは、耐性緑膿菌感染症薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、半合成ペニシリン、セファロスポリン、ラクタム薬、その他に、用途別には、病院、診療所、在宅ケアにセグメント区分し、耐性緑膿菌感染症薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・耐性緑膿菌感染症薬の世界市場概要 ・耐性緑膿菌感染症薬の製造コスト構成分析 ・耐性緑膿菌感染症薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・耐性緑膿菌感染症薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・耐性緑膿菌感染症薬のセグメント分析（種類別） （半合成ペニシリン、セファロスポリン、ラクタム薬、その他）...The global Resistant Pseudomonas Aeruginosa Infections Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Resistant Pseudomonas Aeruginosa Infections Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Resistant Pseudomonas Aeruginosa Infections Drugs market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Resistant Pseudomonas Aeruginosa Infections Drugs in North America, Europe, China, Japan, Southeast Asia and...
  • 世界のタミフル（オセルタミビル）薬市場 2019年
    DATA909X16262 / QYResearch / 2019年11月22日 / ※本調査レポートは、タミフル（オセルタミビル）薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、カプセル、経口液に、用途別には、インフルエンザA、インフルエンザBにセグメント区分し、タミフル（オセルタミビル）薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・タミフル（オセルタミビル）薬の世界市場概要 ・タミフル（オセルタミビル）薬の製造コスト構成分析 ・タミフル（オセルタミビル）薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・タミフル（オセルタミビル）薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・タミフル（オセルタミビル）薬のセグメント分析（種類別） （カプセル、経口液）...The global Tamiflu (Oseltamivir) Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Tamiflu (Oseltamivir) Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Tamiflu (Oseltamivir) Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Tamiflu (Oseltamivir) Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の甲状腺機能低下症薬市場 2019年
    DATA909X09522 / QYResearch / 2019年11月20日 / ※本調査レポートは、甲状腺機能低下症薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、BCT-305、GX-30、レボチロキシンナトリウムSR、リオチロニン、その他に、用途別には、病院、診療所、その他にセグメント区分し、甲状腺機能低下症薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・甲状腺機能低下症薬の世界市場概要 ・甲状腺機能低下症薬の製造コスト構成分析 ・甲状腺機能低下症薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・甲状腺機能低下症薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・甲状腺機能低下症薬のセグメント分析（種類別） （BCT-305、GX-30、レボチロキシンナトリウムSR、リオチロニン、その他）...The global Hypothyroidism Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Hypothyroidism Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Hypothyroidism Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Hypothyroidism Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their Hypothyroidism Drug manufacturing...

    • ◆H&Iグローバルリサーチのお客様（例）◆